Boston Scientific Corporation (BSX)
USD 88.03
(-2.65%)
USD 88.03
(-2.65%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.49 Billion USD | 2.26% |
| 2022 | 9.28 Billion USD | -1.79% |
| 2021 | 9.45 Billion USD | -0.92% |
| 2020 | 9.53 Billion USD | -7.18% |
| 2019 | 10.27 Billion USD | 46.19% |
| 2018 | 7.03 Billion USD | 26.03% |
| 2017 | 5.57 Billion USD | 1.71% |
| 2016 | 5.48 Billion USD | -3.4% |
| 2015 | 5.67 Billion USD | 33.2% |
| 2014 | 4.26 Billion USD | 0.52% |
| 2013 | 4.24 Billion USD | -0.38% |
| 2012 | 4.25 Billion USD | -0.12% |
| 2011 | 4.26 Billion USD | -21.64% |
| 2010 | 5.43 Billion USD | -8.11% |
| 2009 | 5.91 Billion USD | -12.26% |
| 2008 | 6.74 Billion USD | -17.63% |
| 2007 | 8.18 Billion USD | -8.01% |
| 2006 | 8.9 Billion USD | 340.69% |
| 2005 | 2.02 Billion USD | -14.66% |
| 2004 | 2.36 Billion USD | 37.22% |
| 2003 | 1.72 Billion USD | 84.49% |
| 2002 | 935 Million USD | -22.34% |
| 2001 | 1.2 Billion USD | 44.36% |
| 2000 | 834 Million USD | -34.74% |
| 1999 | 1.27 Billion USD | -46.56% |
| 1998 | 2.39 Billion USD | 384.56% |
| 1997 | 493.5 Million USD | 71.47% |
| 1996 | 287.8 Million USD | 305.35% |
| 1995 | 71 Million USD | 64.73% |
| 1994 | 43.1 Million USD | 21.41% |
| 1993 | 35.5 Million USD | 36.02% |
| 1992 | 26.1 Million USD | 3.57% |
| 1991 | 25.2 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 10.88 Billion USD | 2.94% |
| 2024 Q1 | 11 Billion USD | 15.9% |
| 2024 Q2 | 10.93 Billion USD | -0.59% |
| 2023 Q2 | 9.45 Billion USD | 0.95% |
| 2023 FY | 9.49 Billion USD | 2.26% |
| 2023 Q1 | 9.36 Billion USD | 0.89% |
| 2023 Q4 | 9.49 Billion USD | 2.08% |
| 2023 Q3 | 9.29 Billion USD | -1.64% |
| 2022 Q1 | 9.68 Billion USD | 2.45% |
| 2022 Q2 | 9.32 Billion USD | -3.68% |
| 2022 Q4 | 9.28 Billion USD | 3.9% |
| 2022 FY | 9.28 Billion USD | -1.79% |
| 2022 Q3 | 8.93 Billion USD | -4.21% |
| 2021 Q3 | 9.45 Billion USD | -0.05% |
| 2021 Q1 | 9.44 Billion USD | -1.01% |
| 2021 FY | 9.45 Billion USD | -0.92% |
| 2021 Q2 | 9.46 Billion USD | 0.22% |
| 2021 Q4 | 9.45 Billion USD | -0.08% |
| 2020 Q1 | 10.59 Billion USD | 3.11% |
| 2020 Q3 | 9.33 Billion USD | -4.68% |
| 2020 Q4 | 9.53 Billion USD | 2.23% |
| 2020 FY | 9.53 Billion USD | -7.18% |
| 2020 Q2 | 9.78 Billion USD | -7.62% |
| 2019 Q4 | 10.27 Billion USD | -5.48% |
| 2019 Q1 | 9.21 Billion USD | 31.04% |
| 2019 Q2 | 9.52 Billion USD | 3.4% |
| 2019 Q3 | 10.87 Billion USD | 14.15% |
| 2019 FY | 10.27 Billion USD | 46.19% |
| 2018 Q3 | 6.59 Billion USD | 2.12% |
| 2018 Q1 | 5.73 Billion USD | 2.72% |
| 2018 FY | 7.03 Billion USD | 26.03% |
| 2018 Q2 | 6.46 Billion USD | 12.76% |
| 2018 Q4 | 7.03 Billion USD | 6.55% |
| 2017 Q3 | 5.68 Billion USD | -2.62% |
| 2017 FY | 5.57 Billion USD | 1.71% |
| 2017 Q1 | 5.51 Billion USD | 0.55% |
| 2017 Q2 | 5.83 Billion USD | 5.82% |
| 2017 Q4 | 5.57 Billion USD | -1.83% |
| 2016 Q1 | 5.67 Billion USD | 0.0% |
| 2016 Q3 | 5.42 Billion USD | -0.04% |
| 2016 Q2 | 5.42 Billion USD | -4.4% |
| 2016 Q4 | 5.48 Billion USD | 1.09% |
| 2016 FY | 5.48 Billion USD | -3.4% |
| 2015 Q3 | 5.85 Billion USD | 14.61% |
| 2015 Q1 | 4.26 Billion USD | 0.14% |
| 2015 FY | 5.67 Billion USD | 33.2% |
| 2015 Q4 | 5.67 Billion USD | -3.11% |
| 2015 Q2 | 5.11 Billion USD | 19.78% |
| 2014 Q1 | 4.24 Billion USD | 0.21% |
| 2014 FY | 4.26 Billion USD | 0.52% |
| 2014 Q3 | 4.25 Billion USD | -0.07% |
| 2014 Q2 | 4.25 Billion USD | 0.14% |
| 2014 Q4 | 4.26 Billion USD | 0.24% |
| 2013 Q2 | 4.25 Billion USD | -0.05% |
| 2013 Q1 | 4.25 Billion USD | -0.05% |
| 2013 FY | 4.24 Billion USD | -0.38% |
| 2013 Q4 | 4.24 Billion USD | -0.21% |
| 2013 Q3 | 4.24 Billion USD | -0.07% |
| 2012 Q1 | 4.25 Billion USD | -0.05% |
| 2012 Q2 | 4.25 Billion USD | -0.05% |
| 2012 Q3 | 4.25 Billion USD | -0.05% |
| 2012 Q4 | 4.25 Billion USD | 0.02% |
| 2012 FY | 4.25 Billion USD | -0.12% |
| 2011 Q2 | 4.2 Billion USD | -14.68% |
| 2011 Q1 | 4.92 Billion USD | -9.45% |
| 2011 Q3 | 4.26 Billion USD | 1.48% |
| 2011 Q4 | 4.26 Billion USD | -0.05% |
| 2011 FY | 4.26 Billion USD | -21.64% |
| 2010 Q2 | 6.03 Billion USD | 1.89% |
| 2010 Q4 | 5.43 Billion USD | -9.92% |
| 2010 Q3 | 6.03 Billion USD | 0.07% |
| 2010 FY | 5.43 Billion USD | -8.11% |
| 2010 Q1 | 5.92 Billion USD | 0.05% |
| 2009 FY | 5.91 Billion USD | -12.26% |
| 2009 Q4 | 5.91 Billion USD | -1.86% |
| 2009 Q3 | 6.03 Billion USD | -3.52% |
| 2009 Q2 | 6.25 Billion USD | 0.05% |
| 2009 Q1 | 6.24 Billion USD | -7.38% |
| 2008 Q3 | 7 Billion USD | -3.9% |
| 2008 Q1 | 7.56 Billion USD | -7.58% |
| 2008 FY | 6.74 Billion USD | -17.63% |
| 2008 Q4 | 6.74 Billion USD | -3.66% |
| 2008 Q2 | 7.28 Billion USD | -3.74% |
| 2007 Q3 | 8.15 Billion USD | -8.39% |
| 2007 FY | 8.18 Billion USD | -8.01% |
| 2007 Q1 | 8.9 Billion USD | 0.03% |
| 2007 Q2 | 8.9 Billion USD | -0.01% |
| 2007 Q4 | 8.18 Billion USD | 0.39% |
| 2006 Q4 | 8.9 Billion USD | 0.04% |
| 2006 Q1 | 2.64 Billion USD | 30.79% |
| 2006 FY | 8.9 Billion USD | 340.69% |
| 2006 Q2 | 8.89 Billion USD | 236.79% |
| 2006 Q3 | 8.89 Billion USD | 0.0% |
| 2005 FY | 2.02 Billion USD | -14.66% |
| 2005 Q1 | 1.54 Billion USD | -34.73% |
| 2005 Q2 | 2.05 Billion USD | 33.07% |
| 2005 Q3 | 2.51 Billion USD | 22.28% |
| 2005 Q4 | 2.02 Billion USD | -19.65% |
| 2004 Q3 | 2.49 Billion USD | -2.27% |
| 2004 Q2 | 2.55 Billion USD | 52.48% |
| 2004 Q4 | 2.36 Billion USD | -5.17% |
| 2004 Q1 | 1.67 Billion USD | -2.9% |
| 2004 FY | 2.36 Billion USD | 37.22% |
| 2003 Q2 | 1.32 Billion USD | 5.92% |
| 2003 Q3 | 1.64 Billion USD | 23.77% |
| 2003 Q4 | 1.72 Billion USD | 5.18% |
| 2003 FY | 1.72 Billion USD | 84.49% |
| 2003 Q1 | 1.25 Billion USD | 33.8% |
| 2002 Q3 | 1.1 Billion USD | -5.38% |
| 2002 Q4 | 935 Million USD | -15.61% |
| 2002 FY | 935 Million USD | -22.34% |
| 2002 Q1 | 1.24 Billion USD | 3.24% |
| 2002 Q2 | 1.17 Billion USD | -5.79% |
| 2001 FY | 1.2 Billion USD | 44.36% |
| 2001 Q2 | 1.12 Billion USD | 23.79% |
| 2001 Q4 | 1.2 Billion USD | -0.25% |
| 2001 Q3 | 1.2 Billion USD | 7.38% |
| 2001 Q1 | 908 Million USD | 8.87% |
| 2000 FY | 834 Million USD | -34.74% |
| 2000 Q1 | 1.18 Billion USD | -7.51% |
| 2000 Q4 | 834 Million USD | -3.02% |
| 2000 Q2 | 1.01 Billion USD | -14.55% |
| 2000 Q3 | 860 Million USD | -14.85% |
| 1999 Q2 | 1.56 Billion USD | -31.66% |
| 1999 Q1 | 2.28 Billion USD | -4.36% |
| 1999 FY | 1.27 Billion USD | -46.56% |
| 1999 Q3 | 1.32 Billion USD | -15.55% |
| 1999 Q4 | 1.27 Billion USD | -3.18% |
| 1998 Q1 | 572.6 Million USD | 16.03% |
| 1998 FY | 2.39 Billion USD | 384.56% |
| 1998 Q3 | 2.63 Billion USD | 356.15% |
| 1998 Q4 | 2.39 Billion USD | -9.35% |
| 1998 Q2 | 578.3 Million USD | 1.0% |
| 1997 FY | 493.5 Million USD | 71.47% |
| 1997 Q1 | 270 Million USD | -6.18% |
| 1997 Q2 | 350.3 Million USD | 29.74% |
| 1997 Q3 | 415.8 Million USD | 18.7% |
| 1997 Q4 | 493.5 Million USD | 18.69% |
| 1996 Q4 | 287.8 Million USD | 27.35% |
| 1996 Q3 | 226 Million USD | -13.31% |
| 1996 Q2 | 260.7 Million USD | 66.79% |
| 1996 FY | 287.8 Million USD | 305.35% |
| 1996 Q1 | 156.3 Million USD | 120.14% |
| 1995 Q1 | 75.4 Million USD | 74.94% |
| 1995 Q2 | 63.9 Million USD | -15.25% |
| 1995 Q3 | 37.7 Million USD | -41.0% |
| 1995 Q4 | 71 Million USD | 88.33% |
| 1995 FY | 71 Million USD | 64.73% |
| 1994 Q1 | 32 Million USD | -9.86% |
| 1994 Q3 | 39.7 Million USD | 13.43% |
| 1994 Q2 | 35 Million USD | 9.38% |
| 1994 Q4 | 43.1 Million USD | 8.56% |
| 1994 FY | 43.1 Million USD | 21.41% |
| 1993 FY | 35.5 Million USD | 36.02% |
| 1993 Q4 | 35.5 Million USD | 0.0% |
| 1993 Q1 | 26.4 Million USD | 1.15% |
| 1993 Q2 | 30.9 Million USD | 17.05% |
| 1993 Q3 | 35.5 Million USD | 14.89% |
| 1992 Q1 | 42.7 Million USD | 69.44% |
| 1992 FY | 26.1 Million USD | 3.57% |
| 1992 Q3 | 27.7 Million USD | 0.36% |
| 1992 Q2 | 27.6 Million USD | -35.36% |
| 1992 Q4 | 26.1 Million USD | -5.78% |
| 1991 FY | 25.2 Million USD | 0.0% |
| 1991 Q4 | 25.2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Abbott Laboratories | 15.87 Billion USD | 40.2% |
| Allurion Technologies Inc. | 41.85 Million USD | -22577.211% |
| Artivion, Inc. | 359.34 Million USD | -2541.502% |
| Avanos Medical, Inc. | 209.1 Million USD | -4439.455% |
| Butterfly Network, Inc. | 25.02 Million USD | -37827.039% |
| Butterfly Network, Inc. | 25.02 Million USD | -37827.039% |
| Bio-Rad Laboratories, Inc. | 1.4 Billion USD | -575.157% |
| Perspective Therapeutics, Inc. | - USD | -Infinity% |
| CONMED Corporation | 991.25 Million USD | -857.575% |
| Edwards Lifesciences Corporation | 694.9 Million USD | -1265.952% |
| Paragon 28, Inc. | 112.03 Million USD | -8372.731% |
| Glaukos Corporation | 383.73 Million USD | -2373.563% |
| Globus Medical, Inc. | 520.4 Million USD | -1723.968% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -38103.333% |
| Integer Holdings Corporation | 1.04 Billion USD | -811.854% |
| Medtronic plc | 26.04 Billion USD | 63.558% |
| Nevro Corp. | 221.82 Million USD | -4179.01% |
| Owlet, Inc. | 15.21 Million USD | -62281.703% |
| Penumbra, Inc. | 234.34 Million USD | -3950.473% |
| Vicarious Surgical Inc. | 14.83 Million USD | -63896.764% |
| Smith & Nephew plc | 3.08 Billion USD | -207.782% |
| Sonendo, Inc. | 40.35 Million USD | -23423.581% |
| STERIS plc | 3.38 Billion USD | -180.566% |
| Stryker Corporation | 12.99 Billion USD | 26.957% |
| Vapotherm, Inc. | 112.39 Million USD | -8345.441% |
| Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | -58.327% |